Last reviewed · How we verify

NCT05886556

Validity of Lung Ultrasound in Diagnosis of Acute Respiratory Distress Syndrome

Status unknown Last updated 26 June 2023
What this trial tests

trial in of Lung Ultrasound in Diagnosis of Acute Respiratory Distress Syndrome in 57 participants. Status unknown.

Timeline
1 June 2022
Primary endpoint
30 September 2023
30 December 2023

Quick facts

Lead sponsorZagazig University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment57
Start date1 June 2022
Primary completion30 September 2023
Estimated completion30 December 2023
Sites1 location across Egypt

Conditions studied

Sponsor

Zagazig University

Who can join

Adults 19 to 70, any sex, with of Lung Ultrasound in Diagnosis of Acute Respiratory Distress Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the validity of lung ultrasound compared to CT chest and chest radiograph for diagnosis of ARDS and prediction of successful weaning from mechanical ventilation in those patients compared to traditional methods.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Zagazig University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05886556.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing